Clinical value of time-intensity curve of contrast-enhanced ultrasound combined with serologic tests in differential diagnosis of liver benign and malignant tumors

Shan-Ling YAN,Qiang LU,Hong ZHENG,Yan ZHENG

DOI: https://doi.org/10.3969/j.issn.1672-6170.2018.01.013

2018-01-01

Abstract:Objective To evaluate the clinical value of contrast -enhanced ultrasound time-intensity curve(TIC) technology combined with serologic test in differential diagnosis of the liver benign and malignant tumors .Methods The patients with the liver tumor in our hospital were involved in this study and received serologic test and contrast -enhanced ultrasound TIC examination .Accord-ing to the pathological test results ,the patients were divided into the malignant tumor group and the benign tumor group .Serological tests and contrast-enhanced ultrasound indexes were compared between the two groups .Then,the ROC curve analysis was performed to com-pare their diagnostic value.Results A total of 205 patients were involved,in which 89 had malignant tumor and 116 had benign tumor.The serum levels of AFP and the maximum of intensity of the malignant tumor group were higher than these of the benign tumor group (P <0.05).The result of ROC curve showed that the AUC of AFP and the maximum of intensity were 82.7％ and 78.8％,re-spectively.The AUC of combination of two techniques was 91.8％.Conclusion Serological test and ultrasonic imaging all have certain diagnostic value for benign and malignant liver tumors .However,combination of the two methods is better than the two methods alone . This approach is expected to become an accurate noninvasive clinical method .